Analysts estimate that raw material costs will increase in fiscal 2012, though the company cites operational improvements and increased pricing as able to offset this.
By contrast, Jean Weissenbach and his colleagues at Genoscope in France made their estimate by comparing the raw human sequence now available (about 60% of the total when their paper was written) with that of a puffer fish.